NCT03992586 is a NA clinical trial of Wearing pink glasses in Mood, sponsored by Florida Center for Dermatology.

Who is sponsoring NCT03992586?

NCT03992586 is sponsored by Florida Center for Dermatology.

What drugs are being tested in NCT03992586?

Interventions in NCT03992586: Wearing pink glasses, Wearing clear glasses.

Is NCT03992586 still recruiting?

NCT03992586 is currently completed. Last updated 25 August 2020.

Last reviewed 2020-08-25 · How we verify

NCT03992586

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of Rose-colored Glass on Mood

Completed NA Last updated 25 August 2020

What this trial tests

NA trial testing Wearing pink glasses in Mood in 38 participants. Completed in 30 June 2019.

Timeline

30 August 2018

Primary endpoint
30 June 2019

30 June 2019

Quick facts

Lead sponsor	Florida Center for Dermatology
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	prevention
Enrollment	38
Start date	30 August 2018
Primary completion	30 June 2019
Estimated completion	30 June 2019
Sites	1 location across United States

Drugs / interventions tested

Wearing pink glasses
Wearing clear glasses

Conditions studied

Mood — all drugs for Mood →

Sponsor

Florida Center for Dermatology

Who can join

18 and older, any sex, with Mood. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Decades of psychological research has highlighted the impact of visual perception on mood and happiness. The investigators hypothesized that literally seeing the world through rose colored glasses may have an effect on perception, mood, and happiness. After cataract surgery, which classically increases the vividness of perceived colors, patients report significant satisfaction. The investigators therefore sought to explore whether using pink colored lenses leads to a measurable impact on outcomes.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Mood

Currently open trials in the same condition.

NCT07228013 — Examining Effects of Active Plant Engagement on College Student Well-Being and Performance · NA · active not recruiting
NCT07017023 — Combined Blood Pressure Medication and Activity Scheduling for Low Mood · EARLY_PHASE1 · recruiting
NCT07033052 — Developing Resilience and Anxiety Management Through the Arts · NA · recruiting
NCT06950424 — Effect of Black Cumin Seed Oil Supplementation on Cortisol, Stress and Mood · NA · active not recruiting
NCT06716554 — Efficacy and Safety of Shatavari for Treatment of Menopausal Symptoms in Women: A Randomized, Double-blind, Three-arm, P · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03992586 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Florida Center for Dermatology
Last refreshed: 25 August 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03992586.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing